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ABSTRACT
A QUANTITATIVE ANALYSIS OF THE RELATIONSHIP BETWEEN MEDICARE
PAYMENT AND SERVICE VOLUME FOR CATARACT, GLAUCOMA, AND
RETINA PROCEDURES FROM 2005 TO 2009. Dan A. Gong, Jun Lin, and James C.
Tsai. Department of Ophthalmology and Visual Science, Yale University School of
Medicine, New Haven, CT.
The purpose of this study was to evaluate the extent to which changes in the
Medicare Physician Fee Schedule influence the volume and intensity of ophthalmic
services for cataract, glaucoma, and retina procedures.
We conducted a retrospective, longitudinal analysis using a fixed-effects
regression model of Medicare Part B carriers representing all fifty states and the District
of Columbia from 2005 to 2009 to calculate Medicare payment-volume elasticities,
defined as the percent change in Medicare service volume per 1% change in Medicare
payment, for twelve procedures: non-complex and complex cataract surgery (CPT 66984
and CPT 66982), laser trabeculoplasty (CPT 65855), trabeculectomy without and with
previous surgery (CPT 66170 and CPT 66172), aqueous shunt to reservoir (CPT 66180),
laser iridotomy (CPT 66761), scleral reinforcement with graft (CPT 67255), intravitreal
injection (CPT 67028), laser treatment for retinal edema (CPT 67210), laser treatment for
proliferative retinopathy (CPT 67228), and optical coherence tomography (OCT) imaging
(CPT 92135).
For cataract surgery, we found a significant negative Medicare payment-service
volume elasticity. For every 1% decrease in non-complex cataract surgery payment, noncomplex cataract service volume increased 0.27% (95% CI [-0.47, -0.06], p=0.01). For
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every 1% decrease in complex cataract surgery payment, complex cataract service
volume increased 1.34% (95% CI [-1.54, -1.14], p<0.001). For glaucoma procedures, the
payment-volume elasticity was non-significant for four of six procedures studied: laser
trabeculoplasty (elasticity=-0.27, 95% CI [-1.31, 0.77], p=0.61), trabeculectomy without
previous surgery (elasticity=-0.42, 95% CI [-0.85, 0.01], p=0.053), trabeculectomy with
previous surgery (elasticity=-0.28, 95% CI [-0.83, 0.28], p=0.32), and aqueous shunt to
reservoir (elasticity=-0.47, 95% CI [-3.32, 2.37], p=0.74). For laser iridotomy, the
payment-volume elasticity was -1.06 (95% CI [-1.39, -0.72], p<0.001). For scleral
reinforcement with graft, the payment-volume elasticity was -2.92 (95% CI [-5.72, 0.12], p=0.041). For all three retinal procedures, the regression coefficients representing
the payment-volume elasticity were non-significant: intravitreal injection elasticity was 0.75 (95% CI [-1.62, 0.13], p=0.09); laser treatment for retinal edema elasticity was 0.14
(95% CI [-0.38, 0.65], p=0.59); and laser treatment for proliferative retinopathy elasticity
was 0.05 (95% CI [-0.26, 0.35], p=0.77). For every 1% decrease in Medicare payment for
OCT imaging, OCT imaging service volume increased 0.84% (95% CI [-1.36, -0.32],
p=0.002).
Our analysis of twelve ophthalmic procedures from 2005 to 2009 suggest that
there may not be a significant association between Medicare payment and service volume
for many glaucoma and retina procedures. Among those procedures, including cataract
surgery, that have a significant relationship, different elasticities are observed, suggesting
that the volume response to changes in Medicare payments is not uniform across all
Medicare procedures. Further research should explore the contributions of patient
demand and physician supply to this response.
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1. INTRODUCTION
The national debate on improving the economic outlook of the United States has
prompted discussions about effective means to reduce healthcare spending. Currently
representing 18% of gross domestic product (GDP), healthcare expenditures are projected
to rise to 25% of GDP by 2037.1 Concerns about healthcare spending at these levels
include the unsustainable growth in the national debt and diversion of resources away
from other domains.1 Among public healthcare expenditures, Medicare spending
continues to outpace overall economic growth, adding to these concerns.2 Congress first
introduced the modern-day physician fee schedule for rendered Medicare services in the
Omnibus Budget Reconciliation Act (OBRA) of 1989, and then later introduced the
sustainable growth rate (SGR) formula with the passage of the Balanced Budget Act of
1997. Through the SGR formula, policymakers have sought to contain Medicare
spending by adjusting payment rates for over ten thousand practitioner services. Although
the SGR’s implementation was intended to adjust Medicare payments according to
overall economic growth, policymakers and physicians alike have viewed the SGR as a
failed measure both to control healthcare spending and to promote healthcare quality.3,4
Irrespective of Congress’ decision to delay or repeal the SGR in future years, the
original enactment of the SGR to address the increasing volume and intensity of
physician services raised the following question: to what extent can changes in Medicare
payment contain healthcare spending? The answer to this question depends on how
physicians (the supply) and patients (the demand) respond to price changes for
procedures and services. When the Medicare Fee Schedule (now Medicare Physician Fee
Schedule or MPFS) was first implemented under OBRA 1989, both the Health Care
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Financing Administration (HCFA, now Centers for Medicare and Medicaid Services or
CMS) and the Congressional Budget Office assumed that in response to fee reductions,
physicians would recuperate one-half of lost revenue by increasing the volume and
complexity of services, which the HCFA termed the “50% behavioral offset.”5 This
assumption of a behavioral offset was largely based on empirical work conducted by the
Physician Payment Review Commission (PPRC, now the Medicare Payment Advisory
Commission or MedPAC).6,7 Subsequent studies by both the HCFA Office of the Actuary
and independent researchers have found the “physician volume-and-intensity response”
for Medicare payment reductions to be lower at 30-40%.8,9 Based on these studies, CMS
believes that “there is a statistically significant relationship between Medicare price
reductions for physicians' services and partially offsetting increases in the volume and
intensity of such services.”10 However, the last major study to examine this relationship
used data from 1994 to 1996. Thus, new research using updated data would be useful to
study the extent Medicare price changes influence the volume and intensity of services
rendered in today’s healthcare landscape.
To answer this question within the field of ophthalmology, we analyzed the
association between Medicare payment and service volume for cataract, glaucoma, and
retina procedures from 2005 to 2009.

1.1 Cataracts
The choice to study cataract surgery was made for several reasons. First, it is the
most commonly performed surgical procedure among Medicare beneficiaries in the U.S.,
representing a significant proportion of Medicare expenditure.11 According to the
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National Health Interview Survey, 31.0% of Americans between 65 and 74 years old and
53.4% of Americans older than 75 years old have been diagnosed with cataracts.12 The
estimated total prevalence of cataracts in Americans 65 years of age and older is 15.6
million.12 Previous research has found that 61.8 cataract surgeries were performed per
1000 person-years among the Medicare fee-for-service population.11 Fifty percent of
cataract surgeries were performed at an ambulatory surgery center, and fifty percent were
performed at a hospital-based operating room, with nearly 12,000 different surgeons
performing at least one cataract operation during this period.11 Recent figures from the
Beaver Dam Eye Study have also found continually increasing rates of lens extraction
over the past two decades.13 Second, Medicare is the single largest payer for cataract
surgery, and an estimated 80% of cataract surgeries are performed on Medicare
patients.14 Because the vast majority of cataract surgeries are paid for within the
Medicare system, there is less concern for non-Medicare policies influencing the
association between Medicare payment and Medicare cataract service volume compared
to other procedures performed in patient populations with greater diversity in both age
and insurance providers. And third, the MPFS contains two different Current Procedural
Terminology (CPT) codes for cataract surgeries: one for non-complex types (CPT 66984)
and one for complex types (CPT 66982) wherein the latter – requiring devices or
techniques not used in routine cataract surgery – is compensated a higher dollar amount.
The existence of two different procedures for a similar indication allows for the
evaluation of any shifts in the mix or intensity of services furnished to Medicare
beneficiaries.
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1.2 Glaucoma
Glaucoma is a leading cause of blindness in the United States. Previous figures
have estimated that glaucoma affects 2.2 million Americans.15 However, recent research
has estimated that this number is likely higher, finding that approximately 2.4 million
Americans have undiagnosed and untreated glaucoma, which represents over threequarters of all patients with glaucoma.16 Glaucoma represents the most common cause of
blindness in Hispanic persons, the second most common cause in black persons, and the
third most common cause in white persons.17 Moreover, black persons and Hispanic
persons are 4.4 times and 2.5 times to have undiagnosed and untreated glaucoma
compared to white persons.16 As a disease of aging, glaucoma represents a significant
portion of annual Medicare expenditures: in 2000, $1.2 billion were spent on glaucoma
treatment, second only to cataract-related expenditures among major eye diseases.18

1.3 Retina
The number of Americans with visual impairment secondary to retinal diseases
has increased over time.12 Age-related macular degeneration (AMD) and diabetic
retinopathy (DR) combined are the leading causes of blindness among white and
Hispanic persons in the United States.17 Among adults over the age of eighteen, AMD is
estimated to affect 1.1% of the US population and exhibits an age-related increase in
prevalence. Among the 65-74 year old population, 2.8% have AMD; among the 75 and
older population, 8.7% have AMD. Patients with advanced AMD in at least one eye
number 1.75 million. Diabetic retinopathy affects an even greater population of
Americans at an estimated 4 million, and 20% of those affected have vision-threatening
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DR.12 As a percentage of US adults with diabetes, 28.5% and 4.4% of patients have
diabetic retinopathy and vision-threatening DR, respectively, according to recent
estimates.19 Although Medicare spending for retinal therapy ranks behind cataract
surgery and glaucoma treatment, per Medicare beneficiary expenditure for AMD and DR
is increasing18, raising the need to further study retinal procedures.
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2. STATEMENT OF PURPOSE
The purpose of this study was to provide a timely, five-year, quantitative analysis
of Medicare payment and ophthalmic services volume using data for the entire United
States. We included the following twelve procedures – two for cataract, six for glaucoma,
and four for retina – to study the most commonly performed ophthalmic procedures.

Cataract
CPT 66984 – non-complex cataract surgery
CPT 66982 – complex cataract surgery
Glaucoma
CPT 65855 – laser trabeculoplasty
CPT 66170 – trabeculectomy without previous surgery
CPT 66172 – trabeculectomy with previous surgery
CPT 66180 – aqueous shunt to reservoir
CPT 66761 – laser iridotomy
CPT 67255 – scleral reinforcement with graft
Retina
CPT 67028 – intravitreal injection
CPT 67210 – laser treatment for retinal edema
CPT 67228 – laser treatment for proliferative retinopathy
CPT 92135 – optical coherence tomography (OCT) imaging
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For each service, we first described national trends in Medicare payment and
service volume from 2005 to 2009. We then examined the change in service volume for
each procedure following Medicare payment changes by calculating payment-volume
elasticities—defined as the percent change in Medicare service volume per 1% change in
Medicare payment.
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3. METHODS
3.1 Data Sources
This study utilized a retrospective, longitudinal analysis of Medicare Part B
carriers representing all fifty states and the District of Columbia. Part B carriers are
organizations contracted by the Centers for Medicare & Medicaid Services (CMS) that
exercise jurisdiction over a defined geographical area, usually a state, to administer
Medicare Part B policies. For each carrier, 2005-2009 service volume data for each
procedure were obtained through CMS’s Part B Carrier Summary Data Files20, which
includes billed services for the physician/surgeon, assistant surgeon, and ambulatory
surgery center facility service charge by CPT code for each procedure we analyzed (CPT
66984, CPT 66982, CPT 65855, CPT 66170, CPT 66172, CPT 66180, CPT 66761, CPT
67255, CPT 67028, CPT 67210, CPT 67228, CPT 92135). Payment data from 2005 to
2009 were obtained through the Medicare Physician Fee Schedule, which listed the
Facility Price for each procedure.21 Because MPFS data for eighteen states were listed by
sub-divisions within carriers, payment for these states were weighted by population data
from the US Census Bureau22 to determine a single fee schedule amount corresponding to
each carrier, thus matching the reported service volume data. All fee schedule amounts
were adjusted for inflation according to the Consumer Price Index23 using 2005 as the
base year.

3.2 Regression Analysis
We calculated payment-volume elasticities—defined as the percent change in
Medicare service volume per 1% change in Medicare payment—for each procedure using
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a fixed-effects regression model, a standard technique used by the PPRC and other
research groups to assess the volume response to payment changes.7,9,24 In our model, the
Medicare Part B carrier where the procedure was performed served as the independent
unit of analysis.
For each carrier, the MPFS formula is adjusted by a Geographic Practice Cost
Index (GPCI) to account for regional variations in practice costs, resulting in differences
in year-to-year Medicare payment changes across carriers.25 This across-carrier variation
creates a natural experiment to isolate the association between Medicare payment and
service volume within a single carrier. We included a dummy variable representing each
Medicare Part B carrier in the regression model to account for inter-carrier heterogeneity
that was stable over time.26 Thus, the model controlled for time-invariant regional
variations in procedure demand, patient demographics, and physician practices. We
included an additional time variable to control for national trends in service volume due
to factors that affected the entire country. The regression model also controlled for
carrier-level changes in Medicare beneficiary population, number of ophthalmologists,
and income per capita27, in addition to heteroskedasticity to account for non-normally
distributed standard errors as determined by the modified Wald test. Mathematically, the
carrier and time fixed-effects regression model can be represented as follows:

Vijk = β0 + β1Pijk + β2Ajk + β3Bjk + β4Cjk + αj – γk + εijk

Vijk = service volume for procedure i in carrier j and year k
Pijk = Medicare fee for procedure i in carrier j and year k
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Ajk = number of Medicare beneficiaries in carrier j and year k
Bjk = number of ophthalmologists in carrier j and year k
Cjk = income per capita in carrier j and year k
β0 = fixed-effects parameter representing the Y-intercept
αj = fixed-effects parameter that represents the stable characteristics of each
carrier
γk = correction for national trend in service volume
εijk = error term

β1, β2, β3, and β4 are the regression coefficients to be estimated and represent the
effect of their respective covariates on service volume. Because each variable was log
transformed, β1 represents the percent change in service volume per 1% change in
Medicare payment, or the payment-volume elasticity.
For cataract surgery procedures, we also sought to describe any procedural shifts
between non-complex and complex cataract surgeries. A similar fixed-effects model was
used as the aforementioned model except the independent variable P represented the
summed MPFS amount for CPT 66982 and 66984 and the dependent variable V
represented the proportion of total cataract services billed under the complex procedure
code.
All regression analyses were conducted using StataMP 13 (StataCorp LP, College
Station, Texas) with two-sided significance testing and statistical significance set at .05.
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3.3 Projection Analysis
For calculating Medicare payment-service volume elasticities, data up to 2009
were included in the regression analysis. In 2010, the Medicare Physician Fee Schedule’s
payment formula changed on June 1: the conversion factor for the remaining year was
2.2% higher than it was for the first five months.28 Rather than analyzing 2010 data in the
regression and potentially calculating inaccurate estimates due to mismatch in the timing
of payment and service volume data, this study used data starting in 2010 in a set of
projection analyses to determine the accuracy of the Medicare payment-service volume
elasticities derived from 2005-2009 figures. Termed the Elasticity-Adjusted Projection
Model (EAPM), the following formulas were used to predict non-complex and complex
cataract surgical volumes for 2010 and 2011:

PV2010 = AV2009 x (1 + β x ΔP2009-2010) x (1 + ΔG2009-2010) x (1 + γ)
PV2011 = PV2010 x (1 + β x ΔP2010-2011) x (1 + ΔG2010-2011) x (1 + γ)

PVt = predicted volume in year t
AVt = actual volume in year t
β = Medicare payment-service volume elasticity
ΔPt1-t2 = percent change in Medicare payment (calculated as a weighted average
across carriers) from years t1 to t2
ΔGt1-t2 = percent change in national Medicare beneficiary population from years t1
to t2
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γ = average yearly trend in national cataract service volume calculated between
2005 and 2009

The predictions from this model were then compared to an Unadjusted Projection
Model (UPM) that excluded Medicare payment-service volume elasticity and only
factored in Medicare beneficiary population and the average yearly trend in cataract
service volume. Both models were benchmarked against actual 2010 and 2011 service
volumes for CPT 66982 and 66984 procedures.

3.4 Hypothetical Scenario
To understand the magnitude of the Medicare payment-service volume elasticities
on an individual physician level, a hypothetical scenario was constructed of an
ophthalmologist responding to 5%, 10%, and 20% reductions in the Medicare fee
schedule for CPT 66982 and 66984. The scenario assumed that the ophthalmologist
performed 100 cataract surgeries prior to the payment decline, and the pre-reduction
payment amounts and ratio of non-complex to complex cataract surgeries were based on
actual 2011 figures. The elasticity response, describing the change in service volume, was
calculated by multiplying the Medicare payment-service volume elasticity with the
percent change in Medicare payment (5%, 10%, or 20%).

Note: I solely performed all of the above data collection and analyses.
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4. RESULTS
4.1 Cataracts
4.1.1 National Trends (Table 1, Figures 1 and 2)
From 2005 to 2008, average Medicare payment across carriers representing all
fifty states and the District of Columbia decreased every year for both the lower-paid
non-complex and higher-paid complex cataract surgeries, but 2009 saw a small increase
in Medicare fees for both types of procedures. During this five-year period, average
Medicare payment for non-complex cataract surgery decreased from $671.22 to $573.79
(2005 $), a real value decline of 14.5%. For complex cataract surgery, average payment
decreased from $898.92 in 2005 to $806.33 in 2009 (2005 $), a real value decline of
10.3%. Although payment trends for both procedures mirrored each other closely, the
pattern of changes in Medicare service volume differed greatly. The volume of services
billed for non-complex cataract surgery decreased 5.6% from 3,372,757 services/year in
2005 to 3,185,130 services/year in 2009; in contrast, the volume of services billed for
complex cataract surgery increased 105.1% from 112,331 services/year in 2005 to
230,429 services/year in 2009. In aggregate, the total volume of non-complex and
complex cataract services decreased from 3,485,088 services/year in 2005 to 3,415,559
services/year in 2009, a 2.0% decline. Due to the increase in the volume of complex
relative to non-complex cataract services, the proportion of total cataract services billed
under the complex procedure more than doubled from 3.2% in 2005 to 6.7% in 2009 with
an increase of 0.7-1.0 percentage points each year.

20
Table 1. Trends in Medicare Payment and Cataract Service Volume, 2005-2009.
Table 1. Trends in Medicare Payment and Cataract Service Volume, 2005-2009
Procedure
Non-Complex
Cataract Surgery
(CPT 66984)
Complex
Cataract Surgery
(CPT 66982)

Service volume
(services/year)
Average payment
(in 2005 $)
Service volume
(services/year)
Average payment
(in 2005 $)

2005

2006

2007

2008

2009

3,372,757

3,273,864

3,204,754

3,132,367

3,185,130

$671.22

$656.68

$597.27

$561.19

$573.79

112,331

143,108

170,424

200,453

230,429

$898.92

$882.95

$843.81

$794.71

$806.33
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Figure 1. Medicare Payment and Service Volume for Non-Complex (CPT 66984) and
Complex (CPT 66982) Cataract Surgeries.
For each year, service volume equaled the total number of allowed services, including
surgeon, assistant surgeon, and ambulatory surgery center facility service charges, for
cataract surgeries performed in Medicare carriers representing all fifty states and the
District of Columbia. Average payment equaled the weighted average of procedure
payments determined by the Medicare Physician Fee Schedule across those carriers and
is adjusted for inflation using 2005 as the base year.
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Figure 2. Proportion of Total Cataract Services Billed under the Complex Procedure
Code.
Proportion of Total Cataract Services Billed under Complex Procedure is defined as
(number of CPT 66982 services)/(number of CPT 66982 services + number of CPT
66984 services).

Propor%on'of'Total'Cataract'Services''
Billed'under'Complex'Procedure'

10.0%%
9.0%%
8.0%%
7.0%%

6.0%%

6.0%%

5.0%%

5.0%%
4.0%%
3.0%%

6.7%%

4.2%%
3.2%%

2.0%%
1.0%%
0.0%%
2005%

2006%

2007%

Year'

2008%

2009%

24
4.1.2 Regression Results (Table 2)
Using a fixed-effects regression model controlling for time-invariant carrierspecific characteristics, carrier-level changes in Medicare beneficiary population, number
of ophthalmologists, and income per capita, and national trends in cataract service
volume, we calculated payment-volume elasticities for non-complex and complex
cataract surgeries to describe the association between Medicare payment and cataract
service volume. For non-complex cataract surgery, the payment-volume elasticity was 0.27: for every 1% decrease in Medicare payment for CPT 66984, non-complex cataract
service volume increased 0.27% (95% CI [-0.47, -0.06], p=0.01). For complex cataract
surgery, the payment-volume elasticity was -1.34: for every 1% decrease in Medicare
payment for CPT 66982, complex cataract service volume increased 1.34% (95% CI [1.54, -1.14], p<0.001). Thus, the response observed for payment changes to complex
cataract surgery was approximately three times the response for payment changes to noncomplex cataract surgery. When the sum total of CPT 66982 and 66984 payments
decreased by 1%, the proportion of total cataract surgeries billed as complex increased by
1.05% (95% CI [-1.37, -0.73], p<0.001).

25
Table 2. Association between Medicare Payment and Cataract Service Volume, 20052009.
A

Fixed effects model controlling for carrier-level changes in Medicare beneficiary

population, number of ophthalmologists, and income per capita, and for national trends in
cataract service volume.
B

Fixed effects model controlling for carrier-level changes in Medicare beneficiary

population, number of ophthalmologists, and income per capita, and for national trends in
the proportion of total cataract services billed under complex procedure.
* Significant at 0.05 level

Procedure

Non-Complex Cataract
Service Volume (CPT 66984)A

** Significant at 0.01 level

*** Significant at 0.001 level

Variable

% Change in Volume
or Proportion [95% CI]

p-value

CPT 66984 Payment (% Change)

-0.27 [-0.47, -0.06]

0.013*

Medicare Beneficiary Population
(% Change)

1.31 [-0.25, 2.86]

0.10

Number of Ophthalmologists (%
Change)

-0.03 [-0.58, 0.53]

0.92

Income Per Capita (% Change)

0.57 [0.12, 1.02]

0.014*

2006

-0.11 [-0.17, -0.06]

<0.001***

2007

-0.18 [-0.26, -0.10]

<0.001***

2008

-0.28 [-0.39, -0.17]

<0.001***

2009

-0.26 [-0.37, -0.14]

<0.001***

CPT 66982 Payment (% Change)

-1.34 [-1.54, -1.14]

<0.001***

Medicare Beneficiary Population
(% Change)

1.88 [-0.07, 3.83]

0.06

Number of Ophthalmologists (%
Change)

-0.55 [-1.84, 0.74]

0.40

Income Per Capita (% Change)

0.42 [-0.47, 1.30]

0.35

Year

Complex Cataract Service
Volume (CPT 66982)A
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Year

Proportion of Total Cataract
Services Billed under Complex
ProcedureB

2006

0.11 [-0.01, 0.24]

0.08

2007

0.22 [0.05, 0.38]

0.012*

2008

0.26 [0.04, 0.48]

0.02**

2009

0.42 [0.21, 0.64]

<0.001***

CPT 66982 + CPT 66984
Payment (% Change)

-1.05 [-1.37, -0.73]

<0.001***

Medicare Beneficiary Population
(% Change)

0.75 [-0.97, 2.47]

0.39

Number of Ophthalmologists (%
Change)

-0.47 [-1.49, 0.54]

0.36

Income Per Capita (% Change)

-0.08 [-0.82, 0.66]

0.83

2006

0.21 [0.12, 0.31]

<0.001***

2007

0.33 [0.20, 0.46]

<0.001***

2008

0.45 [0.28, 0.63]

<0.001***

2009

0.59 [0.42, 0.76]

<0.001***

Year
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4.1.3 Projection Analysis (Figure 3)
For projecting non-complex and complex cataract surgical volumes, the
Elasticity-Adjusted Projection Model factoring in the estimated Medicare paymentservice volume elasticity was more accurate than the Unadjusted Projection Model.
Compared to the actual non-complex cataract surgical volume in 2010, EAPM’s
prediction error was 1.3% versus UPM’s prediction error of 4.0%; for 2011 non-complex
cataract surgical volume, the EAPM’s prediction error was 6.1% versus 9.6% for UPM.
Similarly, EAPM was more accurate than UPM for predicting 2010 complex cataract
surgical volume (prediction error: -3.2% vs. 10.4%, respectively) and 2011 complex
cataract surgical volume (prediction error: 9.3% vs. 28.4%, respectively).
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Figure 3. Projection of Cataract Surgical Volume and Proportion of Total Cataract
Surgeries Billed as Complex for 2010 and 2011.
Elasticity-Adjusted Projection Model (EAPM) used the Medicare payment-service
volume elasticity and Medicare payment-proportion of complex cataract surgery
elasticity, Medicare beneficiary population growth, and average yearly trend in cataract
surgical volume and proportion over the 2005 to 2009 time frame to predict surgical
volume and proportion in 2010 and 2011. Unadjusted Projection Model (UPM) only used
Medicare beneficiary population growth and average yearly trends.
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B) Complex Cataract Surgical Volume
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4.1.4 Hypothetical Example (Table 3)
In a hypothetical scenario based on 2011 figures, we assumed that an
ophthalmologist performed 8.32 CPT 66982 procedures reimbursed at $899.71 and 91.68
CPT 66984 procedures reimbursed at $643.31 prior to a payment decline. The prereduction income from performing cataract surgeries was $66,464.10. Without any
elasticity response, a 10% decline in payment would reduce that income to $59,817.69, a
decline of $6,646.41. However, factoring the elasticity response, the post-reduction
income is only reduced to $62,153.63, a decline of $4,310.47. For this ophthalmologist,
approximately one-third (35.1%) of the lower income from reduced Medicare payment is
recouped by performing more surgeries. Declines of 5% and 20% in Medicare payment
yield recoupment of 37.1% and 31.2%, respectively.
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Table 3. Hypothetical Scenario of Elasticity Response to 5%, 10%, and 20% Reduction in
Medicare Payment.
A

Assume that the pre-reduction surgical volumes for CPT 66982 is 8.32 procedures and

for CPT 66984 is 91.68 procedures (total cataract surgeries performed = 100), and the
pre-reduction Medicare payments for CPT 66982 is $899.71 and for CPT 66984 is
$643.31 (pre-reduction income = $66,464.10). Ratio of complex to non-complex cataract
surgeries and payment figures (presented in 2005 $) are based on 2011 data.

Pre-ReductionA 5% Reduction 10% Reduction 20% Reduction
Payment
66982

$899.71

$854.73

$809.74

$719.77

66984

$643.31

$611.14

$578.98

$514.65

8.32

8.88

9.44

10.55

66984
Income without Elasticity
Response
(% of Pre-Reduction Income)

91.68

92.92

94.16

96.63

$66,464.10

$63,140.89

$59,817.69

$53,171.28

(100.0%)

(95.0%)

(90.0%)

(80.0%)

Income with Elasticity Response
(% of Pre-Reduction Income)
Change in Income from Elasticity
Response
Change in Income from
Performing More 66982
Procedures
Change in Income from
Performing More 66984
Procedures

-

$64,373.75
(96.9%)

$62,153.63
(93.5%)

$57,324.06
(86.3%)

-

+$1,232.86

+$2,335.94

+$4,152.78

-

+$476.46

+$902.76

+$1,604.91

-

+$756.40

+$1,433.18

+$2,547.87

Surgical Volume
66982
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4.2 Glaucoma
4.2.1 National Trends (Table 4, Figure 4)
From 2005 to 2009, the three highest paid glaucoma procedures by Medicare
were trabeculectomy with previous surgery ($1097.49-$1171.62), trabeculectomy
without previous surgery ($873.62-$940.67), and aqueous shunt to reservoir ($858.69$978.26). For all six glaucoma procedures studied, average Medicare payment across
carriers representing all fifty states and the District of Columbia decreased over the five
years. Payments for trabeculectomy without and with previous surgery were the most
stable with real value declines of only 5.3% and 4.4%, respectively, whereas payments
for laser trabeculoplasty and scleral reinforcement with graft declined the most at 18.0%
and 12.0%, respectively.
During the time frame studied, the two most highly performed glaucoma
procedures were laser trabeculoplasty (889,641 billed services) and laser iridotomy
(457,414 billed services), followed by trabeculectomy without previous surgery (165,535
billed services), aqueous shunt to reservoir (73,231 billed services), trabeculectomy with
previous surgery (69,682 billed services), and scleral reinforcement with graft (47,916
billed services). The volume of billed services for two of the six procedures,
trabeculectomy without and with previous surgery, decreased from 2005 to 2009. The
two procedures with the greatest increase in Medicare service volume were aqueous
shunt to reservoir and scleral reinforcement with graft, which saw increases of 36.5% and
61.9%, respectively.
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Table 4. Trends in Medicare Payment and Glaucoma Service Volume, 2005-2009.
Table 4. Trends in Medicare Payment and Glaucoma Service Volume, 2005-2009
Procedure

2005

2006

2007

2008

2009

Service volume
(services/year)

175,910

173,459

167,866

184,216

188,190

Average payment
(in 2005 $)

$315.41

$310.55

$281.23

$260.99

$258.67

Trabeculectomy
without previous
surgery
(CPT 66170)

Service volume
(services/year)

39,051

36,402

32,147

30,231

27,704

Average payment
(in 2005 $)

$940.67

$926.54

$925.17

$873.62

$891.04

Trabeculectomy
with previous
surgery
(CPT 66172)

Service volume
(services/year)

15,808

15,565

13,316

12,921

12,072

Average payment
(in 2005 $)

$1,171.62

$1,148.32

$1,159.93

$1,097.47

$1,119.51

Service volume
(services/year)

11,674

13,160

16,014

16,451

15,932

Average payment
(in 2005 $)

$978.26

$955.42

$916.04

$858.69

$881.26

Service volume
(services/year)

83,429

83,671

83,739

103,113

103,462

Average payment
(in 2005 $)

$371.15

$367.40

$361.36

$340.35

$339.63

Service volume
(services/year)

7,472

8,639

9,574

10,135

12,096

Average payment
(in 2005 $)

$717.75

$704.73

$673.93

$626.91

$631.51

Laser
trabeculoplasty
(CPT 65855)

Aqueous shunt
to reservoir
(CPT 66180)

Laser iridotomy
(CPT 66761)
Scleral
reinforcement
with graft (CPT
67255)
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Figure 4. Medicare Payment and Service Volume for Glaucoma Procedures.
For each year, service volume equaled the total number of allowed services, including
surgeon, assistant surgeon, and ambulatory surgery center facility service charges, for
cataract surgeries performed in Medicare carriers representing all fifty states and the
District of Columbia. Average payment equaled the weighted average of procedure
payments determined by the Medicare Physician Fee Schedule across those carriers and
is adjusted for inflation using 2005 as the base year.
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B) Trabeculectomy without previous surgery
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D) Aqueous shunt to reservoir
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F) Scleral reinforcement with graft
Average"Payment"

14"

800"

12"

700"
600"

10"

500"

8"

400"

6"

300"

4"

200"

2"

100"

0"

0"
2005"

2006"

2007"
Year'

2008"

2009"

Dollars'(in'2005'$)'

Procedures/Year'(Thousands)'

Volume"

38
4.2.2 Regression Results (Table 5)
Using a fixed-effects regression model controlling for time-invariant carrierspecific characteristics, carrier-level changes in Medicare beneficiary population, number
of ophthalmologists, income per capita, and national trends in glaucoma services volume,
we calculated the payment-volume elasticity for each procedure to describe the
association between Medicare payment and glaucoma services volume. For four of the
six glaucoma procedures studied – laser trabeculoplasty, trabeculectomy without previous
surgery, trabeculectomy with previous surgery, and aqueous shunt to reservoir – the
regression coefficients were non-significant at the 0.05 level. Thus, there is a lack of
evidence to suggest an association between changes in Medicare payment and changes in
service volume for these four procedures. The regression coefficients were significant for
two procedures: laser iridotomy and scleral reinforcement with graft. For laser iridotomy,
the payment-volume elasticity was -1.06 (95% CI [-1.39, -0.72], p<0.001): for every 1%
decrease in Medicare payment for CPT 66761, laser iridotomy service volume increased
1.06%. For scleral reinforcement with graft, the payment-volume elasticity was -2.92
(95% CI [-5.72, -0.12], p=0.041): for every 1% decrease in Medicare payment for CPT
67255, scleral reinforcement with graft service volume increased 2.92%.
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Table 5. Association between Medicare Payment and Glaucoma Service Volume, 20052009.
A

Fixed effects model controlling for carrier-level changes in Medicare beneficiary

population, number of ophthalmologists, and income per capita, and for national trends in
glaucoma services volume.
* Significant at 0.05 level

Procedure

Laser trabeculoplasty

** Significant at 0.01 level

Variable

% Change in Volume
[95% CI]

p-value

CPT 65855 Payment (%
Change)

-0.27 [-1.31, 0.77]

0.61

Medicare Beneficiary
Population (% Change)

4.07 [-1.36, 9.51]

0.14

Number of Ophthalmologists
(% Change)

0.16 [-1.22, 1.54]

0.82

Income Per Capita (%
Change)

0.80 [-0.93, 2.52]

0.36

2006

-0.11 [-0.31, 0.08]

0.25

2007

-0.17 [-0.38, 0.04]

0.10

2008

-0.25 [-0.56, 0.06]

0.11

2009

-0.29 [-0.62, 0.04]

0.087

CPT 66170 Payment (%
Change)

-0.42 [-0.85, 0.01]

0.053

Medicare Beneficiary
Population (% Change)

1.58 [-1.09, 4.26]

0.24

Number of Ophthalmologists
(% Change)

-0.39 [-1.13, 0.35]

0.30

Income Per Capita (%
Change)

-0.40 [-1.65, 0.85]

0.52

-0.12 [-0.24, 0.01]

0.065

Year

(CPT 65855)A

Trabeculectomy without previous
surgery
(CPT 66170)A

*** Significant at 0.001 level

Year
2006

40

Trabeculectomy with previous
surgery

2007

-0.26 [-0.45, -0.07]

0.009**

2008

-0.34 [-0.61, -0.07]

0.013*

2009

-0.50 [-0.81, -0.19]

0.002**

CPT 66172 Payment (%
Change)

-0.28 [-0.83, 0.28]

0.32

Medicare Beneficiary
Population (% Change)

-0.23 [-3.03, 2.58]

0.87

Number of Ophthalmologists
(% Change)

-0.27 [-1.57, 1.03]

0.68

Income Per Capita (%
Change)

0.69 [-0.57, 1.94]

0.28

2006

-0.10 [-0.25, 0.05]

0.18

2007

-0.25 [-0.47, -0.03]

0.025*

2008

-0.36 [-0.67, -0.05]

0.025*

2009

-0.37 [-0.66, -0.08]

0.012*

CPT 66180 Payment (%
Change)

-0.47 [-3.32, 2.37]

0.74

Medicare Beneficiary
Population (% Change)

0.87 [-1.71, 3.45]

0.50

Number of Ophthalmologists
(% Change)

-1.85 [-3.34, -0.36]

0.016*

Income Per Capita (%
Change)

1.45 [0.06, 2.83]

0.041*

2006

-0.11 [-0.33, 0.10]

0.30

2007

-0.003 [-0.37, 0.37]

0.99

2008

-0.06 [-0.66, 0.55]

0.85

2009

-0.03 [-0.56, 0.50]

0.91

CPT 66761 Payment (%
Change)

-1.06 [-1.39, -0.72]

<0.001***

Medicare Beneficiary
Population (% Change)

2.54 [0.84, 4.25]

0.004**

Number of Ophthalmologists
(% Change)

0.23 [-0.73, 1.19]

0.64

Year

(CPT 66172)A

Aqueous shunt to reservoir
(CPT 66180)A

Year
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Income Per Capita (%
Change)
Laser iridotomy

0.35 [-0.66, 1.36]

0.49

2006

-0.19 [-0.24, -0.04]

0.009**

2007

-0.16 [-0.32, -0.004]

0.044*

2008

-0.09 [-0.30, 0.11]

0.38

2009

-0.11 [-0.32, 0.10]

0.32

CPT 67255 Payment (%
Change)

-2.92 [-5.72, -0.12]

0.041*

Medicare Beneficiary
Population (% Change)

3.78 [-0.24, 7.80]

0.065

Number of Ophthalmologists
(% Change)

-1.10 [-2.49, 0.28]

0.12

Income Per Capita (%
Change)

1.15 [-0.18, 2.47]

0.088

2006

-0.10 [-0.31, 0.11]

0.37

2007

-0.20 [-0.54, 0.15]

0.26

2008

-0.48 [-1.07, 0.11]

0.11

2009

-0.35 [-0.96, 0.26]

0.26

Year

(CPT 66761)A

Scleral reinforcement with graft
(CPT 67255)A

Year
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4.3 Retina
4.3.1 National Trends (Table 6, Figure 5)
When comparing Medicare fees from 2005 to 2009 using the same base year,
average payments across Medicare Part B carriers declined for intravitreal injection
(-20.7%), laser treatment for retinal edema (-13.0%), laser treatment for proliferative
retinopathy (-5.8%), and OCT imaging (-14.2%) during this time period. Among these
services, payments for the lower-paid services (intravitreal injection and OCT imaging)
declined to a greater extent than the two higher-paid services (laser treatment for retinal
edema and laser treatment for proliferative retinopathy). Although payments declined
nearly every year for every service, laser treatment for retinal edema did see a real-value
increase from 2008 to 2009, and laser treatment for diabetic retinopathy saw an increase
from both 2007 to 2008 and 2008 to 2009.
Whereas the payment for all four services trended towards the same direction, the
service volume pattern varied from 2005 to 2009. Total service volume declined by
13.5% for laser treatment for retinal edema and by 10.4% for laser treatment for
proliferative retinopathy. Intravitreal injection volume more than quadrupled from
251,311 services in 2005 to 1,297,524 services in 2009, and OCT imaging volume more
than doubled from 3,694,241 services in 2005 to 7,785,030 services in 2009.
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Table 6. Trends in Medicare Payment and Retina Service Volume, 2005-2009.
Table 6. Trends in Medicare Payment and Retina Service Volume, 2005-2009
Procedure

2005

2006

2007

2008

2009

Service volume
(services/year)

251,311

531,652

812,505

1,019,875

1,297,524

Average payment
(in 2005 $)

$204.68

$197.26

$176.98

$165.25

$162.23

Laser
treatment for
retinal edema
(CPT 67210)

Service volume
(services/year)

163,321

147,870

139,361

139,993

141,322

Average payment
(in 2005 $)

$605.92

$584.84

$548.01

$519.79

$527.10

Laser
treatment for
proliferative
retinopathy
(CPT 67228)

Service volume
(services/year)

105,701

99,286

93,437

93,919

94,739

Average payment
(in 2005 $)

$962.54

$920.59

$863.49

$881.02

$907.08

Service volume
(services/year)

3,694,241

4,547,713

5,665,420

6,569,035

7,785,030

Average payment
(in 2005 $)

$44.40

$42.81

$39.90

$38.82

$38.09

Intravitreal
injection (CPT
67028)

OCT imaging
(CPT 92135)
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Figure 5. Medicare Payment and Service Volume for Retina Procedures and OCT
Imaging.
For each year, service volume equaled the total number of allowed services, including
surgeon, assistant surgeon, and ambulatory surgery center facility service charges, for
cataract surgeries performed in Medicare carriers representing all fifty states and the
District of Columbia. Average payment equaled the weighted average of procedure
payments determined by the Medicare Physician Fee Schedule across those carriers and
is adjusted for inflation using 2005 as the base year.
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B) Laser treatment for retinal edema
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C) Laser treatment for proliferative retinopathy
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D) OCT imaging
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4.3.2 Regression Results (Table 7)
To calculate accurate payment-volume elasticity for each Medicare service, the
fixed-effects regression model controlled for time-invariant carrier-specific
characteristics, carrier-level changes in Medicare beneficiary population, number of
ophthalmologists, income per capita, and national trends in retinal services volume and
OCT imaging volume. For all three retinal procedures, the regression coefficients
representing the payment-volume elasticity were non-significant. For intravitreal
injection, the elasticity was -0.75 (95% CI [-1.62, 0.13], p=0.09); for laser treatment for
retinal edema, the elasticity was 0.14 (95% CI [-0.38, 0.65], p=0.59); and for laser
treatment for proliferative retinopathy, the elasticity was 0.05 (95% CI [-0.26, 0.35],
p=0.77). For OCT imaging, a significant association between Medicare payment and
service volume was found: the calculated elasticity was -0.84 (95% CI [-1.36, -0.32],
p=0.002). In other words, for every 1% decrease in Medicare payment for CPT 92135,
OCT imaging volume increased 0.84%.
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Table 7. Association between Medicare Payment and Retina Service Volume, 2005-2009.
A

Fixed effects model controlling for carrier-level changes in Medicare beneficiary

population, number of ophthalmologists, and income per capita, and national trends in
service volume.
* Significant at 0.05 level

Procedure

Intravitreal injection
(CPT 67028)

** Significant at 0.01 level

Variable

% Change in Volume or
Proportion [95% CI]

p-value

CPT 67028 Payment (%
Change)

-0.75 [-1.62, 0.13]

0.09

Medicare Beneficiary
Population (% Change)

1.72 [-0.49, 3.92]

0.12

Number of Ophthalmologists
(% Change)

-0.61 [-1.37, 0.14]

0.11

Income Per Capita (%
Change)

-0.45 [-1.45, 0.56]

0.38

2006

0.70 [0.59, 0.81]

<0.001***

2007

1.06 [0.85, 1.27]

<0.001***

2008

1.22 [0.91, 1.54]

<0.001***

2009

1.44 [1.10, 1.77]

<0.001***

CPT 67210 Payment (%
Change)

0.14 [-0.38, 0.65]

0.59

Medicare Beneficiary
Population (% Change)

-0.70 [-2.18, 0.78]

0.35

Number of Ophthalmologists
(% Change)

0.45 [-0.23, 1.13]

0.19

Income Per Capita (%
Change)

-0.66 [-1.46, 0.13]

0.10

2006

-0.06 [-0.14, 0.01]

0.11

2007

-0.05 [-0.18, 0.08]

0.45

Year

A

Laser treatment for retinal
edema
(CPT 67210)A

*** Significant at 0.001 level

Year
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2008

-0.01 [-0.20, 0.18]

0.90

2009

0.01 [-0.18, 0.21]

0.89

CPT 67228 Payment (%
Change)

0.05 [-0.26, 0.35]

0.77

Medicare Beneficiary
Population (% Change)

-0.37 [-2.62, 1.88]

0.74

Number of Ophthalmologists
(% Change)

0.44 [-0.17, 1.06]

0.15

Income Per Capita (%
Change)

0.21 [-0.67, 1.09]

0.63

2006

-0.06 [-0.15, 0.03]

0.17

2007

-0.12 [-0.26, 0.01]

0.07

2008

-0.12 [-0.32, 0.08]

0.25

2009

-0.11 [-0.33, 0.10]

0.31

CPT 92135 Payment (%
Change)

-0.84 [-1.36, -0.32]

0.002**

Medicare Beneficiary
Population (% Change)

2.89 [0.92, 4.81]

0.005**

Number of Ophthalmologists
(% Change)

-0.46 [1.40, 0.48]

0.33

OCT imaging

Income Per Capita (%
Change)

0.42 [-0.43, 1.28]

0.33

(CPT 92135)A

Year
2006

0.10 [0.01, 0.19]

0.03*

2007

0.24 [0.11, 0.37]

0.001**

2008

0.29 [0.10, 0.48]

0.003**

2009

0.42 [0.22, 0.62]

<0.001***

Laser treatment for
proliferative retinopathy

Year

(CPT 67228)A
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5. DISCUSSION
5.1 Cataracts
Our study of two types of cataract procedures found that Medicare service volume
for non-complex cataract surgery decreased slightly from 2005 to 2009 whereas the
volume for complex cataract services more than doubled during the same time frame. The
billing code for non-complex cataract surgery has existed since the implementation of the
Medicare Fee Schedule, but the code for complex cataract surgery, CPT 66982, was only
introduced in 2001. One of the most common reasons to perform the more complex
cataract extraction is when patients are taking alpha-blockers, a class of medications
known to increase the complexity of cataract operations.29 For the newer complex
cataract procedure, several factors may explain the observed increase in volume,
including 1) improved physician understanding of complex cataract surgery billing codes
over time, 2) increased physician awareness of cataract surgery complications in patients
taking alpha-blockers, 3) improved history-taking by medical staff to ask about alphablocker use in cataract patients, and 4) increased patient awareness to mention alphablocker use prior to cataract operations.
The regression analysis we conducted also finds a statistically significant
association between Medicare payments and service volume for both types of cataract
surgery. Every 1% decrease in Medicare payment for CPT 66984 was associated with a
0.27% increase in non-complex cataract service volume, and every 1% decrease in
Medicare payment for CPT 66982 was associated with a 1.34% increase in complex
cataract service volume. When payments declined by 1% for both types of cataract
surgery, the proportion of total cataract services billed under the complex procedure
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increased by 1.05%, suggesting that decreased payment led to an increase in the intensity
of services rendered. However, there have been studies conducted on periods of
decreasing cataract surgery reimbursement directly before and after the implementation
of the Medicare Fee Schedule that found either no association between Medicare
payment and surgical volume30 or a direct correlation between the two.31 These studies
used different regression techniques or examined physician-year data instead of carrierlevel data, which may explain the divergent findings. Moreover, our study also differs in
that we utilized a 100% sample of Medicare beneficiary data for the entire country
without excluding data from any Medicare Part B carrier or physician. In line with
previous research by the PPRC, the HCFA, and other researchers using the fixed-effects
regression model7,8,9, we find support for an inverse relationship between Medicare fee
changes and the volume and intensity of cataract surgical services rendered.
A set of projection analyses was conducted to test the accuracy of the Medicare
payment-service volume elasticities calculated using 2005 to 2009 data. Compared to the
Unadjusted Projection Model that excluded the Medicare payment-service volume
elasticity, the Elasticity-Adjusted Projection Model was more accurate in predicting the
volumes of CPT 66982 and 66984 surgeries in 2010 and 2011. For both years in which
Medicare payments actually increased, accounting for the elasticity response helped
predict the deceleration in the growth rate of cataract surgical volume compared to
previous years in which Medicare payments largely declined. Although a model to
accurately predict surgical volume in subsequent years requires knowing more than only
the Medicare payment-service volume elasticities, these projection analyses demonstrate
that adjusting for elasticity led to more accurate projections.
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5.2 Glaucoma
During the 2005 to 2009 time period, Medicare payments for laser
trabeculoplasty, trabeculectomy without and with previous surgery, aqueous shunt to
reservoir, laser iridotomy, and scleral reinforcement with graft experienced a real-value
decline ranging from 4.4% to 18.0%. Over this same period, every procedure except for
the two types of trabeculectomies had an increase in Medicare service volume ranging
from 7.0% to 61.9%. The decline in the number of trabeculectomies performed has been
well documented and is thought to be secondary to the introduction of new drug therapies
for lowering intraocular pressure.32,33 Based on descriptive data alone, it is difficult to
determine any relationship between Medicare payment and glaucoma services volume.
To date, the most thorough prior study examining this relationship concluded that argon
laser therapy and trabeculectomy volume seem unrelated to reimbursement rates using
national trend data.32 However, these figures do not take into account a number of factors
that influence nationwide practice patterns for glaucoma management, including greater
awareness of new technologies and procedures, better diagnostic tools such as anterior
segment imaging, and changes in practice guidelines for the use of laser therapy and
surgery versus medical management. In our study, we controlled for these factors by
including a time variable to capture the national trend in glaucoma services volume and
also accounted for unmeasured carrier-specific characteristics that were stable across time
and for carrier-level changes in demographic and provider numbers. With these
appropriate controls, we found that only two of the six procedures studied – laser
iridotomy and scleral reinforcement with graft – had a significant association between
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Medicare payment and service volume. In 2009, these two procedures accounted for less
than one third of the total service volume for the six glaucoma procedures included in our
analysis.
Previous research has remained mixed about the relationship between the volume
of Medicare services rendered and payment depending on which procedure is being
studied. And while initial studies conducted by the Physician Payment Review
Commission suggested a “50% behavioral offset,” subsequent research have found the
“physician volume-and-intensity response” for Medicare payment reductions to be lower
at 30-40%.8,9 Although there is a dearth of previous studies examining Medicare payment
and volume for glaucoma procedures, one group has studied the relationship between
remuneration fees and procedure rates of trabeculoplasties, trabeculectomies, and
glaucoma drainage device implantations in Canada from 1992 to 2007.34 Using a
regression model that employed within-province comparisons and controlled for temporal
trends in procedure rates, the authors found no influence of physician remuneration fee
on procedure rates for these three procedures, consistent with our findings for CPT
65855, CPT 66170, CPT 66172, and CPT 66180.

5.3 Retina
Consistent with the general trend for ophthalmic procedures and services,
payments for intravitreal injection, laser treatment for retinal edema, laser treatment for
proliferative retinopathy, and OCT imaging experienced an overall decrease in real terms
from 2005 to 2009. In contrast, the volume of billed services for these retinal procedures
and OCT imaging had varying trends over this time period. As previously described,
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retinal laser therapy use has seen a modest decline over time whereas the volume of
intravitreal injections has increased substantially.35 For each procedure, total service
volume for the entire United States is dependent upon a number of factors that influence
nationwide practice patterns. These include the development of new medications and
alternative therapies, refinements in pre-existing procedures and surgeries, improvements
in diagnostic imaging, and changes in practice guidelines based on clinical research
findings. The impact of these factors is most evident when examining the volume of
intravitreal injections. The beginning of our study period marked the years in which the
U.S. Food and Drug Administration first approved pegaptanib and ranibizumab for
treatment of neovascular AMD and the initial studies demonstrating the effectiveness of
bevacizumab were published.36,37,38,39 With the introduction of anti-VEGF agents
representing a new frontier in neovascular AMD therapy, it is not surprising to see the
400% growth in intravitreal injections from 2005 to 2009. In addition to improvements in
imaging technology, a rise in treatment of AMD patients may partially explain the
observed increase in OCT imaging as part of the diagnosis and management of
neovascular AMD.
Due to the various factors that influence Medicare service volume over time, it is
difficult to conclude any associations between payment and service volume based on
national-level correlations alone. An accurate assessment of this relationship requires
controlling for both national and local variables that influence service volume
independent of the Medicare fee schedule. Our use of a fixed-effects regression model
served this exact purpose, similar to its role in analyzing glaucoma procedures. We
specifically included a time variable to capture volume trends that affected the entire
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country. For example, for intravitreal injections, we expected to see a rise in service
volume independent of Medicare payment changes due to the development of new AMD
medications. This trend is depicted in the significant positive associations between year
and intravitreal injection volume for each year 2006-2009 as noted in Table 7. Using our
model, we found that there exists a statistically significant association between Medicare
payment and service volume for OCT imaging but not for any of the three retinal
procedures studied.

5.4 Further Considerations
Because our analysis did not include physician-level data, it was not possible to
determine the exact degree of income recoupment seen after payment reductions for
ophthalmic procedures. We can only hypothesize in a constructed model, but the
calculated payment-volume elasticities cannot be directly compared to the 30-50%
“behavioral offset” or “physician response” from prior studies. However, it is clear from
our study that different procedures, even within the same subspecialty, can have varying
magnitudes of payment-volume elasticities. Therefore, assigning a single number as the
volume response to changes in the Medicare fee schedule may oversimplify the
relationship between Medicare reimbursement rates and procedural volume. Our findings
also suggest that most glaucoma and retina procedures may not have any association
between Medicare payment and service volume, raising further flags about grouping all
Medicare procedures and services together when discussing how healthcare providers and
consumers respond to changes in Medicare payment.

56
We raise an additional concern about how the relationship between Medicare
payment and service volume should be characterized moving forward. Two ways that this
relationship has been referred to in the literature are “behavioral offset” and “physician
response,” suggesting that physicians are engaging in behavior to recoup lost income
from declines in Medicare reimbursement by recommending more medical care services
to patients. However, without examining patient and physician decision-making more
closely, it may be misleading to conclude that only physicians drive shifts in procedural
volume. Although a strong income effect can explain why physicians would increase the
volume of Medicare services rendered when faced with declining Medicare payment, a
downward-sloping demand curve representing patients’ preferences can also explain why
decreasing Medicare fees would increase patient demand for services. Lower prices for
medical care services can induce Medicare beneficiaries to seek more care due to lower
out-of-pocket expenses from reduced coinsurance payment. In our research, we elected to
use the term “payment-volume elasticity” as a descriptive term to refer to the association
between Medicare payment and Medicare service volume.

5.5 Limitations and Future Directions
Future streams of research should examine data at physician and patient levels to
determine how the supply and demand for procedures influence payment-volume
elasticities. For example, for laser iridotomy, increased physician and patient awareness
of angle closure glaucoma suspects may be important to study as a factor that impacts
both supply and demand. Similar trends in increased patient awareness of cataracts as a
surgically reversible cause of decreased vision may increase patient demand for cataract
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surgery. An additional variable to consider is the role of increased billing charge capture.
This factor may be particularly important for billing of complex cataract surgery, laser
iridotomy, and scleral reinforcement with graft. Whether driven by decreasing
reimbursement levels or unrelated to Medicare payments, increased capture could explain
the increased service volume for these procedures. In addition, because our findings
suggest that different procedures for cataract, glaucoma, and retina treatments can have
varying payment-volume elasticities, further research on procedures both within
ophthalmology and in other fields of medicine is needed to better characterize the
variation in the volume response to changes in the Medicare fee schedule across different
procedures. As part of this characterization, a central question that remains unexplored is
determining which attributes of a procedure result in that procedure having a significant
association between payment and service volume. From the provider perspective, one
such factor to explore is the relationship between the extent to which a procedure
accounts for a practice’s total revenue and that procedure’s payment-volume elasticity.
Procedures accounting for a greater percentage of a provider’s income may have more
significant associations between payment and service volume. Another factor to consider
is how a procedure’s elective or non-elective nature may affect the impact of Medicare
reimbursements on service volume: for example, consistent with our findings for
trabeculectomy, we expect non-elective procedures to have less significant or nonsignificant associations between Medicare payment and service volume. Identifying the
specific factors that make one procedure more elastic than another can help policymakers
predict future Medicare spending following changes in the Medicare Physician Fee
Schedule.
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Our analysis of twelve ophthalmic procedures from 2005 to 2009 suggest that
there may not be a significant association between Medicare payment and service volume
for many glaucoma and retina procedures. Among those procedures, including cataract
surgery, that have a significant relationship, different elasticities are observed, suggesting
that the volume response to changes in Medicare payments is not uniform across all
Medicare procedures. Approaching the relationship between Medicare payment and
service volume with a more nuanced perspective will help policymakers attain a more
accurate understanding regarding the impact of changes in the Medicare physician
payment system. With forthcoming discussions ranging from a repeal of the SGR
formula to the creation of a value-based per-patient payment system,40,41,42 a better
understanding of both patient and physician behavior will lead to more accurate
projections about future Medicare spending.

59
6. REFERENCES
1. Emanuel E, Tanden N, Altman S, et al. A systemic approach to containing health care
spending. N Engl J Med. 2012 Sep 6;367(10):949-54.
2. Medicare Payment Advisory Commission. A Data Book: Health Care Spending and
the Medicare Program. June 2013. MedPAC website.
http://www.medpac.gov/documents/Jun13DataBookEntireReport.pdf. Accessed
January 15, 2013.
3. McClellan M, Patel K, Sanghavi D. Medicare physician payment reform: will 2014
be the fix for SGR? JAMA. 2014 Feb 19;311(7):669-70.
4. Guterman S. The "doc fix" - another missed opportunity. N Engl J Med. 2014 Jun
12;370(24):2261-3.
5. Department of Health and Human Services, Health Care Financing Administration.
Medicare program: fee schedule for physicians' services: final rule. Federal Register.
November 25,1991; 56:59502-59811.
6. Physician Payment Review Commission. Annual Report to Congress 1993.
Washington, DC: Physician Payment Review Commission; 1993.
7. Ginsburg PB, Hogan C. Physician response to fee changes. A contrary view. JAMA.
1993 May 19;269(19):2550-2.
8. Codespote SM, London WJ, Shatto JD. Physician volume & intensity response. CMS
website. http://www.cms.gov/Research-Statistics-Data-andSystems/Research/ActuarialStudies/Downloads/PhysicianResponse.pdf. Accessed
September 15, 2013.

60

9. Nguyen NX, Derrick FW. Physician behavioral response to a Medicare price
reduction. Health Serv Res. 1997 Aug;32(3):283-98.
10. Centers for Medicare and Medicaid Services. Physician Response. CMS website.
http://www.cms.gov/Research-Statistics-Data-andSystems/Research/ActuarialStudies/PhysicianResponse.html. Accessed September
15, 2013.
11. Schein OD, Cassard SD, Tielsch JM, Gower EW. Cataract surgery among Medicare
beneficiaries. Ophthalmic Epidemiol. 2012 Oct;19(5):257-64.
12. Klein R, Klein BE. The prevalence of age-related eye diseases and visual impairment
in aging: current estimates. Invest Ophthalmol Vis Sci 2013 Dec 13;54(14):ORSF513.
13. Klein BE, Howard KP, Lee KE, Klein R. Changing incidence of lens extraction over
20 years: the Beaver Dam eye study. Ophthalmology. 2014 Jan;121(1):5-9.
14. Erie JC, Baratz KH, Hodge DO, Schleck CD, Burke JP. Incidence of cataract surgery
from 1980 through 2004: 25-year population-based study. J Cataract Refract Surg.
2007 Jul;33(7):1273-7.
15. Friedman DS, Wolfs RC, O'Colmain BJ, et al. Prevalence of open-angle glaucoma
among adults in the United States. Arch Ophthalmol 2004; 122: 532-8.
16. Shaikh Y, Yu F, Coleman AL. Burden of undetected and untreated glaucoma in the
United States. Am J Ophthalmol. 2014 Dec;158(6):1121-1129.e1.

61

17. Congdon N, O'Colmain B, Klaver CC, et al. Causes and prevalence of visual
impairment among adults in the United States. Arch Ophthalmol 2004
Apr;122(4):477-85.
18. Salm M, Belsky D, Sloan FA. Trends in cost of major eye diseases to Medicare, 1991
to 2000. Am J Ophthalmol 2006 Dec;142(6):976-82.
19. Zhang X, Saaddine JB, Chou CF, Cotch MF, Cheng YJ, Geiss LS, Gregg EW,
Albright AL, Klein BE, Klein R. Prevalence of diabetic retinopathy in the United
States, 2005-2008. JAMA. 2010 Aug 11;304(6):649-56.
20. Centers for Medicare and Medicaid Services. Part B Carrier Summary Data File.
CMS website. http://www.cms.gov/Research-Statistics-Data-and-Systems/Files-forOrder/NonIdentifiableDataFiles/Part-B-Carrier-Summary-Data-File.html. Accessed
September 15, 2013.
21. Centers for Medicare and Medicaid Services. Medicare Physician Fee Schedule. CMS
website. http://www.cms.gov/apps/physician-fee-schedule/overview.aspx. Accessed
September 15, 2013.
22. U.S. Census Bureau. Historical Data: 2000s. U.S. Census Bureau website.
http://www.census.gov/popest/data/historical/2000s/index.html. Accessed September
15, 2013.
23. Bureau of Labor Statistics. CPI Inflation Calculator. BLS website.
http://data.bls.gov/cgi-bin/cpicalc.pl. Accessed September 15, 2013.
24. Mitchell JB, Cromwell J. Impact of Medicare payment reductions on access to
surgical services. Health Serv Res. 1995 Dec;30(5):637-55.

62

25. American Medical Association. Overview of RBRVS. AMA website.
http://www.ama-assn.org/ama/pub/physician-resources/solutions-managing-yourpractice/coding-billing-insurance/medicare/the-resource-based-relative-valuescale/overview-of-rbrvs.page. Accessed November 1, 2013.
26. Allison PD. Fixed Effects Regression Models. Thousand Oaks: Sage; 2009.
27. U.S. Department of Health and Human Services. Area Health Resources File. HRSA
website. http://ahrf.hrsa.gov/download.htm. Accessed September 15, 2013.
28. American Medical Association. CMS to Begin Processing Claims with 2.2 Percent
Increase. AMA website. http://www.ama-assn.org/ama/pub/physicianresources/solutions-managing-your-practice/coding-billinginsurance/medicare/medicare-claims-payment.page. Accessed September 15, 2013.
29. Chatziralli IP, Sergentanis TN. Risk factors for intraoperative floppy iris syndrome: a
meta-analysis. Ophthalmology. 2011 Apr;118(4):730-5.
30. Escarce JJ. Effects of lower surgical fees on the use of physician services under
Medicare. JAMA. 1993 May 19;269(19):2513-8.
31. Mitchell JM, Hadley J, Gaskin DJ. Physicians' responses to Medicare fee schedule
reductions. Med Care. 2000 Oct;38(10):1029-39.
32. Paikal D, Yu F, Coleman AL. Trends in glaucoma surgery incidence and
reimbursement for physician services in the Medicare population from 1995 to 1998.
Ophthalmology 2002 Jul;109(7):1372-6.

63

33. Ramulu PY, Corcoran KJ, Corcoran SL, Robin AL. Utilization of various glaucoma
surgeries and procedures in Medicare beneficiaries from 1995 to 2004.
Ophthalmology 2007 Dec;114(12):2265-70.
34. Buys YM, Austin PC, Campbell RJ. Effect of physician remuneration fees on
glaucoma procedure rates in Canada. J Glaucoma 2011 Dec;20(9):548-52.
35. Ramulu PY, Do DV, Corcoran KJ, Corcoran SL, Robin AL. Use of retinal procedures
in medicare beneficiaries from 1997 to 2007. Arch Ophthalmol. 2010
Oct;128(10):1335-40.
36. Rosenfeld PJ, Brown DM, Heier JS, et al; MARINA Study Group. Ranibizumab for
neovascular age-related macular degeneration. N Engl J Med. 2006;355 (14):14191431.
37. Gragoudas ES, Adamis AP, Cunningham ET Jr, Feinsod M, Guyer DR; VEGF
Inhibition Study in Ocular Neovascularization Clinical Trial Group. Pegaptanib for
neovascular age-related macular degeneration. N Engl J Med. 2004;351(27):28052816.
38. Avery RL, Pieramici DJ, Rabena MD, Castellarin AA, Nasir MA, Giust MJ.
Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration.
Ophthalmology. 2006;113(3):363-372.
39. Bashshur ZF, Bazarbachi A, Schakal A, Haddad ZA, El Haibi CP, Noureddin BN.
Intravitreal bevacizumab for the management of choroidal neovascularization in agerelated macular degeneration. Am J Ophthalmol. 2006;142(1):1-9.

64

40. House Ways & Means and Senate Finance Committee Staff. SGR Repeal and
Medicare Physician Payment Reform. October 2013. Available at
http://waysandmeans.house.gov/uploadedfiles/sgr_discussion_draft.pdf. Accessed
January 15, 2014.
41. Wilensky GR. Improving value in Medicare with an SGR fix. N Engl J Med 2014 Jan
2;370(1):1-3.
42. Chien AT, Rosenthal MB. Medicare's physician value-based payment modifier--will
the tectonic shift create waves? N Engl J Med 2013 Nov 28;369(22):2076-8.

